金十数据7月19日讯，保加利亚央行行长迪米塔尔·拉德夫将从明年起开始参与制定欧元区利率。拉德夫 表示，欧洲央行必须比过去更加关注政治（上世纪80年代保加利亚政府突然关闭财政部，拉德夫时任财 政部官员）。最近发生的事件凸显了关税之外潜藏的危险，法国为修复公共财政所做的巨大努力进一步 对其本已虚弱的政府施压，而特朗普也一再谴责鲍威尔。拉德夫表示："政治正日益成为波动性、不确 定性和系统性风险的来源，这是央行在评估时必须考虑的因素，无论是国内还是全球的政治发展，现在 都是我们所处的风险环境的一部分。"拉德夫认为欧洲央行2%的存款利率"处于或非常接近中性区间"， 任何进一步的调整都将是谨慎的，并将基于即将公布的数据。拉德夫将从今年9月开始以观察员的身份 参加欧洲央行会议。 欧洲央行新任管委：欧洲央行应更加关注政治风险 ...

以下文章来源于老魏一凡 ，作者老魏一凡 老魏一凡 . 渤海商品套利研究院长，先后在恒力化工学院，LG化学集团等企业工作，20年年以上化工品现货贸易、期现套保与对冲经验，建立了估值+驱动力完整商品 投研体系，有丰富的研究员培训经验，为20多家企业建立投系数据库投研体系。 文 | 老魏一凡 来源 | 老魏一凡 编辑 | 杨兰 审核 | 浦电路交易员 什么是系统性思维？它要有广度，逻辑完整+闭环。 什么又是目标思维？它要有深度，要聚焦。 举个例子： "减掉20磅是目标思维，正确得饮食习惯与作息规律则是系统思维，以目标为导向的人，充其量，处于成功前的连续失败状态。"（查理芒 格）。 所以，减肥是比较难的，而且容易反复。 饿一周掉10斤，再后面，吃几顿烧烤，体重又回去了。 如果是改变了饮食习惯，那就是系统性思维了，而且体重控制好后，不容易反弹。 我们聊的是一种思维，也是认识。 说白了，就是考虑问题，即要全盘考虑+也要兼顾主要矛盾，两者都很重要。 就怕，想的不周全，只看到了一个点。 而且，这个点还不是 主要矛盾，那就麻烦了。 咱们再回到商品上，回到期货的逻辑，也是要系统性思维看商品。 商品的系统性思维是宏观大逻辑！ 一、 ...

来源：滚动播报 事实上，这并非美国历史上首次出现政治对货币政策的直接干预。1970年11月至1971年12月，时任美联 储主席伯恩斯就迫于总统尼克松的压力，总共降息150个基点，最终引爆美国大通胀，其在业内声誉也 急剧下降。只是当下，这种政治干预的力度与姿态更加直接、露骨，几乎不加掩饰。当今美国政坛极 化、短视化现象严重，政客们显然更多关注短期选举利益，美联储因此承受的压力也可想而知。 从外界猜测的白宫国家经济委员会主任凯文·哈西特等4位潜在人选来看，他们的货币政策取向并非完全 相同，但都带有一定程度的"鸽派"色彩，即更倾向于降息或维持低利率，以支持经济增长。这并非巧 合，而是出于同一个现实：美国经济复苏势头减弱，通胀虽回落但仍处高位，就业市场降温，而美国政 府债务负担又沉重。在中期选举前，为了稳定经济预期、提振市场情绪，货币政策宽松的需求变得更迫 切。从这个角度看，无论美联储主席最终花落谁家，背后推动的都会是同一个变量：政治需要与经济现 实的妥协。 美联储货币政策的不确定性，影响范围远不止美国国内。通过美元在国际货币体系中的主导地位和美债 收益率的全球影响力，其政策变动牵动着全球市场的神经。德银策略师日前警 ...

Core Viewpoint - The recent issuance of the "Notice on the Construction of Zero Carbon Parks" by the National Development and Reform Commission, the Ministry of Industry and Information Technology, and the National Energy Administration marks a significant shift in China's carbon governance approach, moving from individual enterprise emissions reduction to systematic, regional low-carbon transformation [1][4]. Group 1: Policy Framework - The policy document includes one main file and four supporting guidelines, which outline the basic conditions for zero carbon park construction, the application outline for national-level zero carbon parks, a trial indicator system, and carbon emission accounting methods [2]. - The notice establishes construction standards and a management framework for zero carbon parks, with application entities primarily being provincial-level development zones included in the latest "Directory of Approved Development Zones" [2]. - A tiered assessment system is created based on the annual comprehensive energy consumption scale of the parks, categorizing core indicators of unit energy consumption carbon emissions into two tiers [2]. Group 2: Emission Standards - The trial indicator system specifies carbon emission intensity requirements: parks with annual energy consumption of 200,000 to 1,000,000 tons of standard coal must have unit energy consumption carbon emissions ≤0.2 tons/ton of standard coal, while those with consumption ≥1,000,000 tons must meet ≤0.3 tons/ton [2]. - Additional guiding indicators include a clean energy consumption ratio of ≥90%, industrial solid waste comprehensive utilization rate of ≥80%, and waste heat and pressure utilization rate of ≥50% [2]. Group 3: Carbon Accounting - The "Carbon Emission Accounting Method" includes net electricity intake and industrial process emissions in a unified accounting framework, establishing a full lifecycle carbon emission accounting system [3]. - Renewable energy power obtained through green electricity direct supply or green certificate trading is assigned a carbon emission factor of 0, while other electricity is calculated using the national fossil energy power emission factor of 0.8325 kgCO/kWh [3]. - The notice emphasizes that the proportion of electricity supplied directly through green power should not be less than 50% [3]. Group 4: Economic Viability and Financial Support - The shift to park-based management for emissions reduction offers institutional advantages, allowing for the integration of land and policy incentives to encourage enterprise participation [4]. - The construction of zero carbon parks requires economic viability to achieve expected effects, alongside support from policies and financial institutions [4][5]. - The need for green financial support is highlighted, with suggestions for diversified financing models, including the establishment of special funds and the introduction of long-term capital [5]. - Innovative financial products, such as "carbon footprint-linked loans," are being piloted by some commercial banks, linking loan interest rates to the carbon reduction performance of parks [5].

论坛介绍 青年科学家 10²论坛作为 MCES2025（第五届）海洋清洁能源技术与装备高峰论坛 特色活动，将 于 2025年7月23日 在 南通 举办，论坛由 江苏省船舶与海洋工程装备技术创新中心 与 江苏科技 大学联合创新中心 共同主办，采用 10分钟10张PPT+5分钟专家点评 的形式，助力青年科学家 凝练关键科学问题、提出当下解决思路、展望未来发展趋势。 徐立新，长三角船舶与海工装备技术创新中心主任、江苏科技大学海洋资源开发技术创新研究院院长 宁德志，大连理工大学教授、海岸与海洋工程全国重点实验室主任 张永康，广东工业大学教授、广东省海洋能源装备先进制造技术重点实验室主任 崔 琳，长三角船舶与海工装备技术创新中心副主任、中国能源研究会海洋能源专委会副秘书长、中国 光伏行业协会海上光伏专委会副秘书长 报告内容涵盖但不限于 海洋浮式系统性能、系泊技术、结构安全、水动力 等方面 ，主办方会邀 请相关领域 权威专家对报告内容进行点评和打分 ，评出 Top10优秀青年报告并 颁发证书 。 所有参评者需在论坛现场做口头报告 10分钟+5分钟提问 、评委点评并打分，并在 MCES2025（第五 届）海洋清洁能源技术与 ...

Core Viewpoint - The article discusses the new deployment of the "Efficient Handling of One Matter" initiative, which aims to streamline government services and improve efficiency for both enterprises and the public [1][4]. Group 1: Implementation and Mechanism - The State Council's recent opinion emphasizes the need for a normalized approach to the "Efficient Handling of One Matter" initiative, which is crucial for the development of a digital government [2][4]. - The core significance of the normalized approach is to shift government services from a "dispersed reform" model to a "systematic reconstruction," focusing on key matters to enhance cross-departmental collaboration [2][3]. Group 2: Service Improvement Measures - The opinion outlines several measures to promote the normalized implementation of key matters, including integrated handling of cross-departmental issues, reducing overall processing time, and minimizing the number of visits required [4][5]. - It encourages the expansion of service scenarios that are beneficial to both enterprises and the public, aiming to enhance the business environment and improve government service efficiency [5]. Group 3: Data Sharing and Technology - Establishing efficient data sharing channels and implementing the "Government Data Sharing Regulations" are critical for achieving "one-stop" integrated services [6][7]. - The article highlights the importance of utilizing new technologies, such as artificial intelligence, to provide intelligent services that can better meet the needs of enterprises and the public [8]. Group 4: Reform and Collaboration - The article stresses the importance of establishing a user demand response mechanism to transition from passive responses to proactive governance [9]. - It advocates for a national "one chess game" approach to enhance the standardization and integration of government services, ensuring that they are closely aligned with the needs of the public [9].

新能源及有色金属日报 | 2025-07-08 进口压力有所显现 升贴水仍面临下行风险 市场要闻与重要数据 期货行情： 2025-07-07，沪铜主力合约开于 79810元/吨，收于 79270元/吨，较前一交易日收盘-0.58%，昨日夜盘沪铜主力合 约开于 79,370元/吨，收于 79,390 元/吨，较昨日午后收盘下降0.15%。 现货情况： 据 SMM 讯，昨日电解铜现货市场呈现弱势整理格局。SMM1#电解铜报价79,800-79,970元/吨，当月合约升水区间 收窄至50-140元/吨，均价95元/吨，较前日回落20元。盘面波动加剧，主力合约早间下探79,700元/吨后短暂反弹， 但受进口集中到货影响，最终维持弱势震荡。市场呈现明显分化特征：主流平水铜实际成交回落至60-80元/吨，而 优质品牌如金川大板仍维持110-140元/吨的高升水，显示市场对品质的差异化需求。区域方面，常州等地成交进一 步走弱至平水附近，俄罗斯非标货源则因集中到货导致溢价快速缩水。从供需结构看，持续扩大的月差（250-280 元/吨）与进口压力形成双重压制，预计短期内现货升水仍将面临下行压力。 重要资讯汇总： 宏观与地缘方面 ...

Cogent Biosciences (COGT) Conference Call Summary Company Overview - **Company**: Cogent Biosciences - **Focus**: Development of bezuclastinib for the treatment of non-advanced systemic mastocytosis (SM) Key Industry Insights - **Industry**: Rare disease treatment, specifically systemic mastocytosis - **Current Treatment Landscape**: Limited options for patients with non-advanced SM, highlighting the unmet medical need for effective therapies Core Findings from the SUMMIT Trial - **Trial Results**: The SUMMIT trial demonstrated positive top-line results, meeting all primary and key secondary endpoints with statistically significant benefits compared to placebo [5][24][54] - **Patient Population**: The trial included 179 patients with moderate to severe symptoms of non-advanced SM, with a significant percentage being female [20][22] - **Primary Endpoint**: The mean change in total symptom score at week 24 was significantly better in the bezuclastinib group (24.32) compared to placebo (15.41), with a placebo-adjusted effect size of 8.91 [25] - **Secondary Endpoints**: Significant reductions in serum tryptase levels and other markers of mast cell burden were observed, with 87.4% of patients achieving at least a 50% reduction in serum tryptase [26][54] Safety Profile - **Adverse Events**: Bezuclastinib showed a favorable safety profile, with 98% of patients experiencing treatment-emergent adverse events (TEAEs) compared to 88% in the placebo group [29] - **Serious Adverse Events**: Serious AEs were low, with 5% in placebo versus 4.2% in the bezuclastinib cohort [29] - **Common AEs**: Hair color changes (69%), altered taste (23.7%), and nausea (22%) were among the most common TEAEs [30] Future Outlook - **Regulatory Submissions**: Cogent plans to submit a New Drug Application (NDA) for bezuclastinib later in 2025, aiming for commercial approval [6][54] - **Upcoming Trials**: Results from two additional pivotal trials (APeX and PEAK) are expected later in 2025, which could further establish bezuclastinib's role in treating advanced SM and gastrointestinal stromal tumors (GIST) [9][51] - **Market Potential**: The company is positioned to become a leader in the treatment of non-advanced SM, with a strong financial position to support its initiatives [54] Competitive Landscape - **Comparison with Avapritinib**: The conference highlighted the potential for bezuclastinib to outperform avapritinib in terms of efficacy and safety, with physicians expressing interest in switching patients who are not well-controlled on avapritinib [60][88] - **Patient Preferences**: Patients currently on avapritinib expressed satisfaction but showed a strong interest in switching to bezuclastinib based on the promising SUMMIT trial results [93] Additional Considerations - **Patient Quality of Life**: The trial results indicate not only symptomatic relief but also potential disease modification, which is crucial for improving patients' overall quality of life [96][98] - **Ongoing Research**: Further analysis of the SUMMIT trial data is anticipated, which may provide deeper insights into specific symptom domains and long-term outcomes [87][90] This summary encapsulates the key points from the Cogent Biosciences conference call, focusing on the promising results of the SUMMIT trial and the potential impact of bezuclastinib in the treatment landscape for systemic mastocytosis.

作 者丨倪雨晴 编 辑丨骆一帆 视频编辑丨柳润瑛 设 计丨黎旭廷 华为的昇腾，让英伟达黄教主都坐不住了。他公开表示，华为昇腾CloudMatrix 384超节点， 部分性能上甚至超过英伟达的产品。 华为的384超节点方案，就像全真七子用剑阵打黄药师，集群一起上，黄药师还真有点招架不 住。 海外专业机构SemiAnalysis更是直接点名：384超节点的整体计算能力是英伟达GB200机柜的 1.6倍！ 在单芯片性能受限、制裁持续的情况下，华为昇腾是真能打，还是"自嗨"？它是如何与英伟 达竞争的？国产算力究竟到了什么水平？还有什么差距？ 今天，我们就带着这些问题，一口气了解对垒英伟达的国产芯片，昇腾。 和英伟达"掰手腕" 昇腾此前非常低调，它是华为打造的一款AI芯片。它不是拿来打游戏的显卡，也不是电脑中 的CPU，而是专门针对AI任务的加速芯片NPU，是一颗纯纯的"AI处理器"。 目前昇腾最主力的产品叫"昇腾910"。但以往的昇腾芯片，更多是作为"备胎"使用的——因为 美国断供，英伟达、AMD最高端的芯片买不到，很多厂商只能硬着头皮用国产，而昇腾已经 是国产芯片中的佼佼者。 过去几年，昇腾其实主要用在AI"推理" ...

Core Viewpoint - Huawei's Ascend is positioning itself as a competitive alternative to NVIDIA by leveraging a system-level engineering breakthrough rather than focusing solely on individual chip performance [5][12]. Technical Breakdown - The "CloudMatrix 384 Super Node" consists of 384 Ascend 910 chips and 192 Kunpeng CPUs, interconnected to function as a single efficient unit [2][4]. - Unlike NVIDIA's reliance on copper cables for inter-chip communication, Huawei has developed a fully peer-to-peer interconnect bus using optical cables, significantly enhancing data transmission efficiency [8][10]. - Huawei's approach includes advanced mathematical algorithms for scheduling, deep hardware-software collaboration, and effective thermal management, contributing to the overall performance of the Ascend system [11]. Competitive Landscape - Huawei acknowledges a gap in chip technology, as NVIDIA has advanced to 3nm processes, while Huawei's chips are still a generation behind [14]. - The software ecosystem remains a challenge, with Huawei's CANN still needing to catch up to NVIDIA's established CUDA framework [15]. - Despite these challenges, Huawei is gaining traction in the Chinese market, especially as companies adapt to domestic chips due to restrictions on NVIDIA's products [16]. Industry Dynamics - The domestic AI chip market is diversifying into three main factions: tech giants like Huawei, pure chip manufacturers, and niche players focusing on specific applications [16]. - The pressure from U.S. sanctions has inadvertently spurred growth in China's semiconductor industry, allowing companies like Huawei to innovate and optimize system performance rather than solely competing on chip specifications [16][17].